Pretomanid是一种实验性抗结核药，体外作用于结核分枝杆菌的最小抑制浓度(MIC)为0.015-0.25 μg/mL。

参考文献

[1] Lenaerts AJ, Gruppo V, Marietta KS, et al. Preclinical testing of the nitroimidazopyran PA-824 for activity against Mycobacterium tuberculosis in a series of in vitro and in vivo models. Antimicrob Agents Chemother. 2005 Jun;49(6):2294-301. doi: 10.1128/AAC.49.6.2294-2301.2005(IF:4.715).

[2] Ahmad Z, Peloquin CA, Singh RP, et al. PA-824 exhibits time-dependent activity in a murine model of tuberculosis. Antimicrob Agents Chemother. 2011 Jan;55(1):239-45. doi: 10.1128/AAC.00849-10(IF:4.715).

-25~-15℃保存，有效期3年。